Vascular endothelial growth factor (VEGF) genotype and serum concentration in patients with pancreatic adenocarcinomaand chronic pancreatitis

Journal of Physiology and Pharmacology

Volumn 61, Issue 6, 2010, Pages 711-716

  Talar Wojnarowska, R ^a   Gasiorowska, A ^a   Olakowski, M ^b   Lekstan, A ^b   Lampe, P ^b   Smolarz, B ^c   Romanowicz Makowska, H ^c   Kulig, A ^c   Malecka Panas, E ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Angiogenesis; Chronic pancreatitis; Pancreatic adenocarcinoma; Vascular endothelial growth factor gene polymorphism

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CAUCASIAN; CHRONIC PANCREATITIS; CONTROLLED STUDY; DISTANT METASTASIS; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PROTEIN BLOOD LEVEL; TUMOR LOCALIZATION; TUMOR VOLUME; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; POLYMORPHISM, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79251483848     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Folkman J. Angiogenesis. Annu Rev Med 2006; 57: 1-18.
2. Iwasaki J, Nihira S. Anti-angiogenic therapy against gastrointestinal tract cancers. Jpn J Clin Oncol 2009; 39: 543-551.
3. Toomey DP, Murphy JF, Conlon KC. Cox-2, VEGF and tumor angiogenesis. Surgeon 2009; 7: 174-180.
4. Ferrante M, Pierik M, Henckaerts L, et al. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 870-878.
5. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
6. Karayiannakis AJ, Bolanaki H, Syrigos KN, et al. Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis. Cancer Lett 2003; 194: 119-124.
7. Kobayashi A, Yamaguchi T, Ishihara T, et al. Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: differential diagnosis, tumor progression and patients survival. Pancreas 2005; 31: 74-78.
8. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 2000; 6: 3147-3152.
9. Heer K, Kumar H, Read JR, Fox JN, Monson JR, Kerin MJ. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin Cancer Res 2001; 7: 3491-3494.
10. Buchler P, Reber HA, Ullrich A, et al. Pancreatic cancer growth is inhibited by blockade of VEGF-RII. Surgery 2003; 134: 772-782.
11. Bruckner HW, Hrehorovich VR, Sawhney HS. Bevacizumab as treatment for chemotherapy-resistant pancreatic cancer. Anticancer Res 2005; 25: 3637-3639.
12. Hotz HG, Hines J, Masood R, et al. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. Surgery 2005; 137: 192-199.
13. Mukhopadhyay D, Zeng H, Bhattacharya R. Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) - receptors signaling. Mol Cell Biochem 2004; 264: 51-61.
14. Kuehn R, Lelkes PI, Bloechle C. Angiogenesis, angiogenic growth factors and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer. Pancreas 1999; 18: 96-103.
15. Beddy D, Watson RW, Fitzpatrick JM. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohǹs disease. Br J Surg 2004; 91: 72-77.
16. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003; 63: 812-816.
17. Lee SJ, Lee SY, Jeon HS, et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 571-575.
18. Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 2006; 35: 21-28.
19. Maltese P, Canestrari E, Ruzzo A, et al. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int J Colorectal Dis 2009; 24: 165-170.
20. Zhai R, Liu G, Zhou W, et al. Vascular endothelial growth factor genotypes, haplotypes, gender and risk of non-small cell lung cancer. Clin Cancer Res 2008; 14: 612-617.
21. Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. Influence of vascular endothelial growth factor single nucleotide polymorphism on tumor development in cutaneous malignant melanoma. Genes Immun 2002; 3: 229-232.
22. Abe A, Sato K, Habuchi T, et al. Single nucleotide polymorphism in the 3'untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 2002; 198: 181-190.
23. Zhai R, Liu G, Asomaning K, et al. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis 2008; 29: 2330-2334.
24. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC. Vascular endothelial growth factor gene -460 C/T polymorphism is a biomarker for prostate cancer. Urology 2003; 62: 374-377.
25. Sordello S, Bertrand N, Plouet J. Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. Biochem Biophys Res Commun 1998; 251: 287-290.
26. Watson CJ, Webb NA, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-1235.
27. Zhai R, Gong MN, Zhou W, et al. Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS. Thorax 2007; 62: 718-722.
28. Kiec-Wilk B, Grzybowska-Galuszka J, Polus A, et al. The MAPK-dependent regulation of the JAGGED/NOTCH gene expression be VEGF, BFGF or PPAR gamma mediated angiogenesis in HUVEC. J Physiol Pharmacol 2010; 61: 217-225.
29. Kiec-Wilk B, Razny U, Mathers JC, Dembinska-Kiec A. DNAmethylation, induced by beta-carotene and arachidonic acid, plays a regulatory role in the pro-angiogenic VEGFreceptor (KDR) gene expression in endothelial cells. J Physiol Pharmacol 2009; 60: 49-53.
30. Bellone C, Novarino A, Chiappino I, et al. Circulating vascular endothelial growth factor and interferon-gamma - inducible protein - 10 levels in pancreatic cancer during chemotherapy. Anticancer Res 2005; 25: 3287-3291.
31. Shimada H, Takeda A, Nabeya Y, et al. Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma. Cancer 2001; 92: 663-669.
32. Shang ZJ, Li JR, Li ZB. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2002; 31: 495-498.
33. Mall JW, Schwenk W, Philipp AW, et al. Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuronspecific enolase or lactate dehydrogenase. Respirology 2002; 7: 99-102.
34. Liu CD, Tilch L, Kwan D, McFadden DW. Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer. J Surg Res 2002; 102: 31-34.
35. Czarkowska-Paczek B, Bartlomiejczyk I, Przybylski J. The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise. J Physiol Pharmacol 2006; 57: 189-197.
36. Awata T, Inoue K, Kurihara S. A common polymorphism in the 5̀-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51: 1635-1639.
37. Summers AM, Coupes BM, Brennan MF, et al. VEGF-460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol Dial Transplant 2005; 20: 2427-2432.